Systemic inflammatory response index and its obesity-related derivatives as predictors of heart failure: A cross-sectional study from NHANES 2017-2020

全身炎症反应指数及其与肥胖相关的衍生指标作为心力衰竭的预测因子:一项基于2017-2020年NHANES数据的横断面研究

阅读:1

Abstract

INTRODUCTION: Heart failure (HF), a growing public health concern, is primarily driven by metabolic disorders. While the systemic inflammatory response index (SIRI) has demonstrated prognostic value in cardiometabolic diseases, its role in predicting HF remains unclear. Given the link between obesity and inflammation, integrating SIRI with obesity-related measures may enhance the stratification of HF risk. This study aims to examine the association between SIRI, integrated with obesity-related indices, and HF. METHODS: Data from NHANES 2017-2020 were used, including 6572 adults aged 20-80 years with complete data on key indices. HF was defined based on self-reported physician diagnosis. SIRI was calculated as (neutrophil × monocyte)/lymphocyte count. Receiver operating characteristic (ROC) analysis was performed to assess the predictive value of inflammatory and obesity indices on HF risk. Multivariable logistic regression models, restricted cubic spline (RCS) and Interaction tests were used to examine the association between the index of interest and HF. RESULTS: Of 6572 participants, 170 (2.6%) had HF. The SIRI × BMI × WHR index showed the highest predictive value (AUC: 0.68), improving in non-smokers (AUC: 0.73) and individuals with diabetes (AUC: 0.71). RCS analysis indicated a linear, dose-response relationship, with multivariable logistic regression analysis revealed the strongest association in the fourth quartile (AOR: 2.00, 95% CI: 1.07-3.75), and stronger effects in non-smokers (AOR: 7.25, 95% CI: 2.04-25.76) and those with diabetes (AOR: 5.63, 95% CI: 1.25-25.39). CONCLUSION: The SIRI × BMI × WHR index demonstrated predictive ability and an association with HF, particularly among individuals with diabetes and non-smokers. Given its accessibility and cost-effectiveness, this index may serve as a valuable tool for HF screening.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。